Medpace Holdings (MEDP) Stock Price, Quote, News & History | Benzinga

Medpace Holdings Inc (MEDP) Stock Price, Quote, News & History

MEDPNASDAQ

Trade with Public

Trade with Public

$590.30

-6.82-1.14%

At close: Aug 18, 5:00 PM EST

$590.30

N/A

After Hours: 4:00 PM EST

OverviewNews Earnings Forecast Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$595.81

Close

$590.30

Volume / Avg.

131.41K / 318.20K

Day Range

$588.38 - $598.77

52 Wk Range

373.00 - 677.90

Market Cap

$16.48B

P/E Ratio

35.08

Dividend Yield

-

Exchange

NASDAQ

RSI

58

Short Interest

7.81%

Days to Cover

3.82

Recent Medpace Holdings, Inc. News

Medpace Soars After Q2 Beat, Strong Backlog Fuels Higher 2026 Outlook

Medpace says second-quarter earnings and revenue beat estimates, backed by stronger bookings, backlog growth and higher 2026 guidance.

Vandana Singh

Brent Tops $100, Alphabet, Tesla Sink Nasdaq 100: Stock Market Today

Stocks slide Thursday as Brent crude breaks $100 and the 10-year yield hits an 18-month high, while Alphabet and Tesla earnings revive AI-spending doubts.

Piero Cingari

Lockheed Martin, Quest Diagnostics, Thermo Fisher Scientific And Other Big Stocks Moving Higher On Thursday

U.S. stocks were down as Dow Jones fell 450 points on Thursday. Lockheed Martin (LMT) shares rose 11.4% on better-than-expected results. Other big gainers were NVE Corp (NVEC), Gibo Holdings Ltd (GIBO), Novocure Ltd (NVCR), Cleveland-Cliffs Inc (CLF), Merlin Inc (MRLN), Medpace Holdings Inc (MEDP), Oatly Group AB (OTLY), Imax Corp (IMAX), United Rentals Inc (URI), Oceaneering International Inc (OII), and Quest Diagnostics Inc (DGX).

Avi Kapoor

This HCA Healthcare Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Top Wall Street analysts changed outlook on top names, see all changes on analyst ratings page. HCA downgraded and price target slashed.

Avi Kapoor

This Truist Financial Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Top Wall Street analysts changed outlook on some top names. Check all changes on analyst ratings page. See how others view TFC stock before buying.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

752.66M

Investing Cash Flow (TTM)

-45.77M

Financing Cash Flow (TTM)

-249.53M

Free Cash Flow (TTM)

706.69M

Capital Expenditure (TTM)

-45.97M

Net Change in Cash (TTM)

457.37M

Analyst Trends and Forecast

1

1

Mar

2

2

Apr

3

3

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.8

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$16.28B

PE Ratio (TTM)

35.08

PE Ratio (FWD)

34.72

PEG Ratio (TTM)

3.20

PS Ratio (TTM)

6.19

PB Ratio (TTM)

38.42

Earnings Yield % (TTM)

2.85%

Earnings Yield % (FWD)

2.88%

EV / EBITDA (TTM)

26.64

Price / EBITDA (TTM)

28.16

Price / Free Cash Flow (TTM)

24.36

Book Value / Share

$15.54

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$502.69M

Debt to Equity

0.28

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$595.81

Close

$590.30

Volume / Avg.

131.41K / 318.20K

Day Range

$588.38 - $598.77

52 Wk Range

373.00 - 677.90

Market Cap

$16.48B

P/E Ratio

35.08

Dividend Yield

-

Exchange

NASDAQ

RSI

58

Short Interest

7.81%

Days to Cover

3.82

About

Sector

Health Care

Industry

Life Sciences Tools & Services

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including ...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Medpace Holdings (MEDP) stock?

A

You can purchase shares of Medpace Holdings (NASDAQ:MEDP) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Medpace Holdings (MEDP) competitors?

A

Other companies in Medpace Holdings’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), IQVIA Holdings Inc (NYSE:IQV) and Waters Corp (NYSE:WAT).

Q

What is the forecast, or price target, for Medpace Holdings (MEDP) stock?

A

Medpace Holdings has a consensus price target of $510.47.

Q

What is the current price for Medpace Holdings (MEDP)?

A

The stock price for Medpace Holdings (NASDAQ: MEDP) is $590.3 last updated August 18, 2026 at 4:00 PM EDT.

Q

Does Medpace Holdings (MEDP) pay a dividend?

A

There are no upcoming dividends for Medpace Holdings.

Q

When is Medpace Holdings (NASDAQ:MEDP) reporting earnings?

A

Medpace Holdings does not have any upcoming earnings scheduled.

Q

Is Medpace Holdings (MEDP) going to split?

A

There is no upcoming split for Medpace Holdings.

Q

What sector and industry does Medpace Holdings (MEDP) operate in?

A

Medpace Holdings is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.